DBT’s National Pharma Mission To Fund COVID-19 Vaccine Project

COVID-19 Vaccine Using Rhabdovirus Vector – Funded By DBT The global
response to the unprecedented COVID-19 pandemic is drawing on the
lessons learned from other disease outbreaks in the past. The
development of a COVID-19 vaccine must balance manufacturing speed and
technical feasibility with clinical safety and immunogenicity trial
outcomes, in the setting of a […]

The post DBT's National Pharma Mission To Fund COVID-19 Vaccine
Project appeared first on BioTecNika .

https://www.biotecnika.org/2020/06/covid-19-vaccine-using-rhabdovirus-vector-funded-by-dbt/

Biotech News

Comments

Popular posts from this blog

Pharma Production Executive Post Vacancy @ Intas

Pharos of Chaos

HILR Intersession: Mollie Crawford-Volk: Velazquez' "Las Meninas" and its Modern Progeny